If your patients are suffering from mental health challenges, the last thing they want is to go through a lengthy trial and error process with multiple medications. The process can be frustrating and leave patients feeling worse, not better. Fortunately, the GeneSight Psychotropic test can provide information that helps you provide patients medications that lead to relief. By examining how your patient’s DNA responds to specific medications such as antidepressants, this simple, painless test lets you know which medications may not work for your patient, so you can get more of them into remission faster.
Kroger Prescription Plans is focused on improving the health and wellness of all our members. As part of your plan benefits, we would like you to know that you are eligible to receive a test called GeneSight® Psychotropic with no out-of-pocket costs or copayments. This test identifies certain genetic characteristics that are related to how an individual may react to select medications. The results of the GeneSight Psychotropic test may help your doctor in choosing a better treatment if you have been struggling to find the right medication.
GeneSight Testing Significantly Improved Remission Rates for Depression Compared to Treatment as Usual
Collect a DNA sample by painlessly swabbing the inside of your cheek
The sample is sent to our lab for analysis
Just 36 hours later, your patient’s report is available for review.
Guided by insights from your report, you can avoid being undermined by genetic variability.
Become a provider of the GeneSight test
See what happens when the GeneSight® test becomes part of a clinician’s practice.
Learn more about pharmacogenomics
A Medscape CME Course Available Now
The ABCs of Pharmacogenomics in Clinical Practice is designed to increase clinicians’ knowledge and competence on the emerging role of pharmacogenomics testing in psychiatric care. The faculty, Roger S. McIntyre, MD and Sagar Parikh, MD, will interpret current information, including the latest clinical data, and share their experience with available tests, to build confidence in decision making and competence in optimizing the use of combinatorial pharmacogenomics to improve patient outcomes.